The Study of Ginkgo Leaf Dropping Pills and Huperzine A Injection Combined With Median Nerve Electrical Stimulation in the Treatment of Cognitive Impairment After Brain Injury

This study will conduct a single-center clinical trial to explore the initial therapeutic effect of ginkgo biloba dropping pills, huperzine A injection and median nerve electrical stimulation in patients with cognitive impairment.

Inclusion Criteria: * Be over 18 years old * Residual cognitive impairment due to brain injury * No previous history of brain-related diseases except this one Exclusion Criteria: * The patient had severe underlying disease and unstable vital signs * The patient was complicated with consciousness disorder and could not cooperate with cognitive function assessment * Allergic to drugs or contraindications in drug use * There are contraindications of median nerve electrical stimulation